"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 42 | 42 |
| 1997 | 0 | 53 | 53 |
| 1998 | 0 | 47 | 47 |
| 1999 | 0 | 59 | 59 |
| 2000 | 0 | 58 | 58 |
| 2001 | 1 | 62 | 63 |
| 2002 | 0 | 94 | 94 |
| 2003 | 0 | 121 | 121 |
| 2004 | 1 | 117 | 118 |
| 2005 | 0 | 129 | 129 |
| 2006 | 0 | 130 | 130 |
| 2007 | 0 | 141 | 141 |
| 2008 | 0 | 200 | 200 |
| 2009 | 0 | 184 | 184 |
| 2010 | 0 | 192 | 192 |
| 2011 | 0 | 236 | 236 |
| 2012 | 0 | 248 | 248 |
| 2013 | 0 | 299 | 299 |
| 2014 | 0 | 301 | 301 |
| 2015 | 1 | 319 | 320 |
| 2016 | 0 | 345 | 345 |
| 2017 | 0 | 311 | 311 |
| 2018 | 0 | 370 | 370 |
| 2019 | 0 | 362 | 362 |
| 2020 | 0 | 316 | 316 |
| 2021 | 0 | 238 | 238 |
| 2022 | 0 | 69 | 69 |
| 2023 | 0 | 66 | 66 |
| 2024 | 0 | 251 | 251 |
| 2025 | 0 | 210 | 210 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Balloon guide catheter impact on angiographic and clinical outcomes in distal medium vessel occlusion stroke thrombectomy. J Neurointerv Surg. 2026 Feb 16; 18(3):639-646.
-
Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies. Blood Adv. 2026 Feb 10; 10(3):694-706.
-
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals. Clin Infect Dis. 2026 Feb 09; 82(1):75-85.
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Comparative efficacy and safety of stent retrievers as a bailout strategy following failed contact aspiration technique in acute stroke thrombectomy. J Neurointerv Surg. 2026 Jan 13; 18(2):390-398.
-
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenstr?m macroglobulinemia from the ASPEN study. Blood Adv. 2025 Dec 23; 9(24):6538-6546.
-
Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis. Am J Kidney Dis. 2026 Mar; 87(3):313-323.
-
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients. Clin Cancer Res. 2025 Dec 01; 31(23):5027-5036.
-
Stent frame deformation of self-expanding transcatheter heart valves in bicuspid aortic stenosis and impact on valve performance. Eur Heart J Cardiovasc Imaging. 2025 Nov 26; 26(12):1842-1851.
-
Improved technical outcomes with converting thrombectomy techniques after failed first pass recanalization. J Neurointerv Surg. 2025 Nov 18; 17(12):1333-1339.